CSTL — Castle Biosciences, Inc.
7 mentions in the last 24 hours · 0.02% of all mentions
Why people talked about CSTL (2026-11-06)
- Castle Biosciences reported Q3 2026 earnings results that exceeded analyst expectations by $0.22 EPS.
- Management released a slide presentation (Exhibit 99.2) on November 5, 2026, for use in future meetings.
| RSS Bundle | 3 | news |
| Bluesky | 1 | community |
| GDELT | 1 | news |
| Marketaux | 1 | news |
| SEC EDGAR 8-K | 1 | filings |